AMGN compared with KYMR: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

KYMRKymera Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

KYMRKymera Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

460.55▲+0.06%· post 460.41· delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

KYMRKymera Therapeutics, Inc.

131.73▲+2.82%· post 131.72· delayed

After hoursNov 6 '26delayed

Mkt cap$10.9BRevenue$65MQ2 FY26Revenue$39MFY25

Compare

After hoursNov 6 '26delayed

AMGNAmgen Inc

KYMRKymera Therapeutics, Inc.

460.55▲+0.06%post 460.41delayed

Price

131.73▲+2.82%post 131.72delayed

$249.0B

Mkt cap

$10.9B

Q3 FY26$10.4B

Revenue

$65MQ2 FY26

FY25$36.8B

Revenue

$39MFY25

AMGN460.55▲+0.06%vsKYMR131.73▲+2.82%After hoursNov 6 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

KYMR: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

AMGN, solidKYMR, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only KYMR 4

GILDGilead Sciencescustomer

VERXVertex Pharmaceuticalscustomer

SNYSanoficustomer

SNYNFSanoficustomer

Role chip = supplier or customerSource: SEC EDGAR